Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Frontiers in Immunology|April 27, 2019
Deciphering the Roles of Innate Lymphoid Cells in CancerMelanie Bruchard, Francois GhiringhelliOncoimmunology|June 27, 2013
Immune effects of 5-fluorouracil: Ambivalence mattersFrançois Ghiringhelli, Melanie Bruchard, Lionel ApetohThe Oncologist|August 4, 2009
What is the role of cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma?Caroline Robert, Francois GhiringhelliBiomedical Journal|August 29, 2014
Enhancing the anticancer effects of 5-fluorouracil: current challenges and future perspectivesFrancois Ghiringhelli, Lionel ApetohOncoimmunology|September 20, 2023
Chemoimmunotherapy triggers immune responses targeting microsatellite stable colorectal cancerMarion Thibaudin, Francois GhiringhelliAnticancer Research|November 17, 2012
Metronomic cyclophosphamide with cisplatin and bevacizumab: a new chemotherapeutic regimen for refractory anaplastic ependymomaVeronique Lorgis, Olivier Varbedian, Francois GhiringhelliWorld Journal of Gastroenterology|February 23, 2013
Degarelix as a new antiangiogenic agent for metastatic colon cancer?Francois Ghiringhelli, Nicolas Isambert, Sylvain LadoireCancers|June 2, 2021
Targeting BRAF and RAS in Colorectal CancerHelene Bellio, Jean David Fumet, Francois GhiringhelliWorld Journal of Gastroenterology|September 15, 2009
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot studyFrancois Ghiringhelli, Boris Guiu, Bruno Chauffert, et al.World Journal of Gastrointestinal Oncology|April 19, 2018
<i>EGFR</i> amplification induces sensitivity to anti<i>EGFR</i> therapy in pancreatic acinar cell carcinomaCorentin Richard, Julie Niogret, Romain Boidot, et al.Pageof 10